Surgical Innovations Group plc

LSE SUN
£0.70 0.0000 0.0000%
Today share price
UK
Sector: Healthcare Industry: Medical Devices
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 21.25 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
513.05M
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
932.82M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
27.27 %

Upcoming events Surgical Innovations Group plc

All events
No upcoming events scheduled

Stock chart Surgical Innovations Group plc

Stock analysis Surgical Innovations Group plc

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
- 4046.62
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
60.07 164.48
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
- 1951.78
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
- 5.77
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
- 4.06

Price change Surgical Innovations Group plc per year

0.50£ 0.70£
Min Max

Summary analysis Surgical Innovations Group plc

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Surgical Innovations Group plc

Revenue and net income Surgical Innovations Group plc

All parameters

About company Surgical Innovations Group plc

Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite port access systems; YelloPort +plus Resposable port access systems; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and build of instruments. In addition, the company distributes specialist medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.
Address:
Clayton Wood House, Leeds, United Kingdom, LS16 6QZ
Company name: Surgical Innovations Group plc
Issuer ticker: SUN
ISIN: GB0004016704
Country: UK
Exchange: LSE
Currency: £
Sector: Healthcare
Industry: Medical Devices
Site: https://www.sigroupplc.com